Medication info

Micatell Plus Tablet 80/12.5 mg

Prescription medicationTabletOralExpired
Ingredient · strength
Telmisartan›80mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Aprogen Biosciences Co., Ltd.
Appearance
White or whitish rectangular tablet
Packaging
30 tablets/box [(10 tablets/Alu-Alu x 3)]
Approval status
Expired

MFDS item code 202001198 · Approved 2020.02.20

This product's status changed to Expired on 2025.02.20. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of essential hypertension
Who takes it
Adults · Children
Adult dose
Adults Take once daily with a beverage, with or without food, in patients whose blood pressure is not adequately controlled with telmisartan alone. Before switching to this medicine, which contains fixed doses of each component, it is recommended that the dose of each component be adjusted individually. When clinically appropriate, switching directly from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg given as separate tablets or with the combination product. Sodium or volume depletion should be corrected before starting this medicine. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment. Do not administer this medicine to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment This medicine should be administered with caution to patients with mild to moderate hepatic impairment. Do not administer more than 40/12.5mg of this medicine per day. Do not administer this medicine to patients with severe hepatic impairment (see Precautions for Use 2.). Thiazide diuretics should be administered with caution to patients with impaired liver function. Elderly patients No dose adjustment is necessary.
Child dose
The safety and efficacy of this medicine have not been established in children under 18 years of age.

Ingredients

Manufacturer
Aprogen Biosciences Co., Ltd.

Efficacy & effects

Treatment of essential hypertension

  • Primary hypertension
View approved original text

This medication is used for patients with primary hypertension in whom blood pressure control is insufficient with Telmisartan alone. It helps effectively manage the patient's blood pressure and reduce the risk of complications.

How to take

Adult dose

Adults Take once daily with a beverage, with or without food, in patients whose blood pressure is not adequately controlled with telmisartan alone. Before switching to this medicine, which contains fixed doses of each component, it is recommended that the dose of each component be adjusted individually. When clinically appropriate, switching directly from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg given as separate tablets or with the combination product. Sodium or volume depletion should be corrected before starting this medicine. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment. Do not administer this medicine to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment This medicine should be administered with caution to patients with mild to moderate hepatic impairment. Do not administer more than 40/12.5mg of this medicine per day. Do not administer this medicine to patients with severe hepatic impairment (see Precautions for Use 2.). Thiazide diuretics should be administered with caution to patients with impaired liver function. Elderly patients No dose adjustment is necessary.

Child dose

The safety and efficacy of this medicine have not been established in children under 18 years of age.

Precautions

This medication may pose serious risks to the fetus and newborn during pregnancy, particularly in the second and third trimesters, and should be discontinued immediately if pregnancy is confirmed. This medication should not be used in patients with allergies to the ingredients or additives, pregnant or breastfeeding women, and patients with severe liver or kidney diseases. Elderly patients or those with hyperkalemia, liver or heart conditions should use this medication with caution, and regular skin checks are recommended due to a potential increased risk of skin cancer. Adverse symptoms such as dizziness, low blood pressure, electrolyte imbalances, gastrointestinal disturbances, and skin rashes may occur while taking this medication; if any abnormal symptoms arise, immediate consultation with healthcare professionals is necessary. Patients with diminished liver or kidney function may find the elimination of this medication challenging, so they should discuss with healthcare professionals before use, and regular blood tests should be conducted to monitor kidney function and electrolyte status. This medication can interact with other blood pressure medications, diuretics, lithium, potassium supplements, etc., so it is crucial to inform your doctor or pharmacist of any concurrent medications. This medication should not be used during pregnancy or while breastfeeding for safety reasons. Overdosage may lead to hypotension, electrolyte abnormalities, dehydration, etc., so the prescribed dosage must be followed strictly, and immediate medical attention is required if adverse reactions occur. This medication is not recommended for children under 18 years of age, and it should be administered to the elderly while monitoring for blood pressure-lowering effects with caution.

Side effects

  • Bronchitis
  • pharyngitis
  • sinusitis
  • hypokalemia
  • hyperuricemia
  • hyponatremia
  • anxiety
  • depression
  • insomnia
  • sleep disorder
Show 105 more
  • dizziness
  • syncope
  • paresthesia
  • visual impairment
  • blurred vision
  • vertigo
  • tachycardia
  • arrhythmia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • respiratory distress
  • pneumonia
  • pulmonary edema
  • diarrhea
  • dry mouth
  • distension
  • abdominal pain
  • constipation
  • dyspepsia
  • vomiting
  • gastritis
  • liver dysfunction
  • liver disease
  • angioedema
  • erythema
  • pruritus
  • rash
  • hyperhidrosis
  • urticaria
  • low back pain
  • muscle spasm
  • myalgia
  • arthralgia
  • limb pain
  • systemic lupus erythematosus
  • erectile dysfunction
  • chest pain
  • influenza-like illness
  • pain
  • increased blood uric acid
  • increased blood creatinine
  • increased blood creatine phosphokinase
  • increased liver enzymes
  • upper respiratory tract infection
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • eosinophilia
  • thrombocytopenia
  • anaphylactic reaction
  • hypersensitivity
  • hyperkalemia
  • hypoglycemia
  • drowsiness
  • cough
  • dry mouth
  • abdominal discomfort
  • eczema
  • drug rash
  • toxic skin rash
  • achiness
  • renal impairment
  • asthenia
  • increased blood creatinine
  • decreased hemoglobin
  • sialadenitis
  • non-melanoma skin cancer
  • thrombocytopenic purpura
  • hemolytic anemia
  • bone marrow failure
  • leukopenia
  • agranulocytosis
  • aplastic anemia
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • lupus-like syndrome
  • erythema multiforme
  • systemic lupus erythematosus
  • acute renal failure
  • diabetes
  • renal impairment
  • jaundice
  • cholestasis
  • necrotizing vasculitis
  • acute respiratory distress syndrome
  • nausea
  • pancreatitis
  • fever
  • facial flushing
  • malaise
  • fatigue
  • weight loss
  • proteinuria
  • itching
  • myalgia
  • headache
  • buoyancy
  • lip and hand tremors
  • sensory hypersensitivity
  • gum disease
  • lip dryness
  • decreased vision
  • hypoglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it must be stored in a tightly sealed container. It should also be kept at a temperature between 1 and 30 degrees Celsius to maintain its efficacy.

Appearance and packaging

Appearance

White or whitish rectangular tablet

Package unit

30 tablets/box [(10 tablets/Alu-Alu x 3)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.